cardiac pharm Flashcards
drugs for essential hypertension
diuretics, ACEi, ARBs, CCBs
drugs for hypertension in CHF
diuretics, ACEi, ARBs, CCBs B-blockers (conpensated CHF only), K sparing diuretics
drugs for hypertension in DM
diuretics, ACEi, ARBs, CCBs, alpha blockers
reason for giving ACEi to DM pts
protective against diabetic nephropathy
-dine drugs
CCBs
CCB Mechanism
block voltage gated L-type Ca channels in cardiac and smooth muscles and reduce muscle contactability
CCB NOT to be used in arrythmia
nifepidine
tox of CCBs
cardiac depression,AV block, peripherial edema, flushing dizzyness, constipation
hydralazine MOA
increase cGMP –> smooth muscle relaxation –> vasodilates arterioles –> reduces afterload
hydralazine use
severe hypertension, CHF.. Coadministered with B blocker to prevent reflex tachycardia
first line therapy for hypertension in pregnancy
hydralazine (with methyldopa)
treatment for malignant hypertension
nitroprusside, CCBs, labetalol, fenoldapam
tx of hydralazine
compensitory tachycardia, fluid retention, nausea, headache, angina, Lupus-like syndrome
Tox of nitroprusside
cyanide poisoning
MOA of nitroprusside
increase GMP by direct release of NO.
moa of fenoldapam
D1 receptor agonist, conorany, peripheral, renal and splachnic vasodilation
“monday disease”
development of tolerance during the week for isosorbide. loss of tolerance during the weekend. Start back up with tachycardia, dizzyness and headache
drugs NOT to be used in angina
pindolol and acebutolol
antilipid with the best effect on LDL
statins
MOA of statin
inhibit conversion of HMG-CoA to mevalonate
Side effects of statins
hepatotox, rhabdo
antilipid with the best effect on HDL
niacin
MOA of niacin
inhibits lipolysis, reduces VLDL circulation
Side effects of niacin
flushing, hyperglycemia, hyperuricemia
Bile acid resins examples
cholestyramine, colestipol, colsevelam
Bile acid resin effect
moderate lowering of LDL, slightly higher HDL and TGs
Bile acid MOA
prevent intestinal reaborption of bile acids - liver must use cholesterol to make more
Bile acid side effects
taste bad and screws with your gut. malaboprtion of fat soluable vitamins. cholesteral gallstones
ezetimibe effect
moderate lower LDL
ezetimibe MOA
prevent cholesteral reabsorption at SI brush border
ezetimibe side effects
rare increase in LFTs, diarrhea
fibrate effects
large reduction in TGs
fibrate MOA
upregulate LPL, clearing TGs
firate side effects
myositis, hepatotox, cholesterol gallstones
MOA of digoxin
direct inhibition of Na/K ATPase leading to direct inhibition of Na/Ca exchangers. increase in intracelluar Ca –> increase contractability.
Also stimulates Vagus nerve to slow HR
use of digoxin
CHF, Afib (slow conduction at AV and depression of SA)
tox of digoxin
cholinergic (N/V, diarrha, blurry yellow vision)
increasedPR, lower QT, T wave inversion,a rrythmia - AV block
poor prognostic indicator in digoxin tox
hypokalemia
antidote for dig tox
normallize K+, lidocaine, anti-digoxin fab fragments, Mg2+
effect of Na+ channel blocker antiarrythmics (Class I)
slow or block conduction in abnormal pacemaker cels
causes increased tox in class 1 antiarrythmics
low K
class 1A antiarrythmics
Quinidine, Procainamide, disopyramide
class 1A antiarrythmics action
increase AP duration, increase refreactory period, increase QT
class 1A antiarrythmics use
A and V arrythmias. Ectopic supraventricular tachy and v tach
quinadine tox
cinchoism
procanamide tox
SLE-type syndrome
disopyramide
Heart failure, thrombocytopenia, torsades de pointes
class IB antiarrythmics effect
lower AP duration. affects aischemuc or depolarized purkinjie and ventriculartissue
class IB antiarrythmics use
acute ventricular arrythmias (especially post-MI) and digitalis induced arrythmias
class IB antiarrythmics
lidocaine, mexiletine, tocainide (phenytoin can be listed)
tox of class IB antiarrythmics
CNS stimulation/depression, CV depression
class IC antiarrythmics
flecainide, propafenone
class IC antiarrythmics effect
useful in ventricular tachycardias that progress to VF and in tractable SVT - used as last resort in refractory tachy
people NOT to use class IC antiarrythmics with
post-MI, structural heart disease
class IC antiarrythmics tox
proarrythmic, significantly prologs refreactory period in AV node
antiarrythmic beta blockers
metoprolol, proanolol, emolol, atenolol, timolol
antiarrythmic beta blockers MOA
decreases SA and AV nodal activity by deceraseing cAMP and lowering Ca currents
short acting antiarrythmic beta blocker
esmolol
use of antiarrythmic beta blockers
Vtach, SVT, slowing ventricular rate during afib and a flutter
tox of antiarrythmic beta blockers
impotence, worse asthma, bradycardia, CHF, sedation, may mask hypoglycemia
side effect of metoprolol
dyslipidemia (treat OD with glucogon)
can exacerbate vasospasm in prinzmetal’s
propanolol
K+ channel blockers (Class III antiarythmics)
amidorone, ibutilide, dofeilite, soralol
effect of Class III antiarythmics
increase AP duration, used when other antiarrythmics fail, increase QT interval
tox of sotalol
torsades des pointes, excessive Beta blockade
tox of amidorine
pulmonary fibrosis, hepatotox, hypothyroidism (check PFTs, LFTs, TFTs) corneal and skin deposits, neuro effects,bradycardia, AV block
MOA of verapamil, diltiazem
CCB, lower conduction velocity, increase ERP and PR inverval, prevents nodal arrythmia
tox of verapamil, diltiazem
constipation, flushing, edema, sinus node depression
adenosine MOA
sends K out of cells - hyperpolarizes and lowering intracellular calcium,
adenosine is the DOC for
supraventricular tachy (VERY short acting)
T 1/2 for dig
40 hours
blocks effects of adenosine
theophylline and caffiene
Mg++ used for
torades des points and dig tox